rs16990748

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004429.5(EFNB1):​c.*732A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0273 in 107,250 control chromosomes in the GnomAD database, including 64 homozygotes. There are 817 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.027 ( 64 hom., 817 hem., cov: 21)
Exomes 𝑓: 0.086 ( 9 hom. 7 hem. )
Failed GnomAD Quality Control

Consequence

EFNB1
NM_004429.5 3_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.352

Publications

3 publications found
Variant links:
Genes affected
EFNB1 (HGNC:3226): (ephrin B1) The protein encoded by this gene is a type I membrane protein and a ligand of Eph-related receptor tyrosine kinases. It may play a role in cell adhesion and function in the development or maintenance of the nervous system. [provided by RefSeq, Jul 2008]
EFNB1 Gene-Disease associations (from GenCC):
  • craniofrontonasal syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Genomics England PanelApp, Orphanet, Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_004429.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0708 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004429.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EFNB1
NM_004429.5
MANE Select
c.*732A>C
3_prime_UTR
Exon 5 of 5NP_004420.1P98172

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EFNB1
ENST00000204961.5
TSL:1 MANE Select
c.*732A>C
3_prime_UTR
Exon 5 of 5ENSP00000204961.4P98172
EFNB1
ENST00000851101.1
c.*732A>C
3_prime_UTR
Exon 4 of 4ENSP00000521160.1

Frequencies

GnomAD3 genomes
AF:
0.0272
AC:
2921
AN:
107209
Hom.:
64
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.0735
Gnomad AMI
AF:
0.00151
Gnomad AMR
AF:
0.0147
Gnomad ASJ
AF:
0.0225
Gnomad EAS
AF:
0.0200
Gnomad SAS
AF:
0.0403
Gnomad FIN
AF:
0.00969
Gnomad MID
AF:
0.0130
Gnomad NFE
AF:
0.00606
Gnomad OTH
AF:
0.0172
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0861
AC:
29
AN:
337
Hom.:
9
Cov.:
0
AF XY:
0.0483
AC XY:
7
AN XY:
145
show subpopulations
African (AFR)
AF:
0.800
AC:
4
AN:
5
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3
South Asian (SAS)
AF:
0.500
AC:
2
AN:
4
European-Finnish (FIN)
AF:
0.0153
AC:
4
AN:
261
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.327
AC:
18
AN:
55
Other (OTH)
AF:
0.125
AC:
1
AN:
8
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.438
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0273
AC:
2924
AN:
107250
Hom.:
64
Cov.:
21
AF XY:
0.0266
AC XY:
817
AN XY:
30696
show subpopulations
African (AFR)
AF:
0.0734
AC:
2149
AN:
29264
American (AMR)
AF:
0.0147
AC:
151
AN:
10266
Ashkenazi Jewish (ASJ)
AF:
0.0225
AC:
58
AN:
2575
East Asian (EAS)
AF:
0.0201
AC:
68
AN:
3383
South Asian (SAS)
AF:
0.0404
AC:
103
AN:
2547
European-Finnish (FIN)
AF:
0.00969
AC:
51
AN:
5262
Middle Eastern (MID)
AF:
0.0144
AC:
3
AN:
209
European-Non Finnish (NFE)
AF:
0.00607
AC:
313
AN:
51607
Other (OTH)
AF:
0.0183
AC:
27
AN:
1474
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
99
198
298
397
496
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.556
Hom.:
2297

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.27
DANN
Benign
0.59
PhyloP100
0.35
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs16990748;
hg19: chrX-68061229;
COSMIC: COSV52662649;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.